Hispolon as an inhibitor of TGF-β-induced epithelial-mesenchymal transition in human epithelial cancer cells by co-regulation of TGF-β-Snail/Twist axis

Oncology Letters

Volumn 14, Issue 4, 2017, Pages 4866-4872

  Hong, Darong ^a   Park, Min Ju ^a   Jang, Eun Hyang ^a   Jung, Bom ^a   Kim, Nam Jung ^a   Kim, Jong Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Epithelial mesenchymal transition; Hispolon; Invasion; Migration; Transforming growth factor

Indexed keywords

HISPOLON; PHENOL DERIVATIVE; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

A-549 CELL LINE; ARTICLE; CARCINOMA; CELL CULTURE; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CELL VIABILITY; EPITHELIAL MESENCHYMAL TRANSITION; IC50; IMMUNOFLUORESCENCE; MCF-7 CELL LINE; MTT ASSAY; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING; WOUND HEALING;

EID: 85028914675     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2017.6789     Document Type: Article

References (40)

1. Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65: 5-29, 2015.
2. Sleeman JP, Nazarenko I and Thiele W: Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 128: 2511-2526, 2011.
3. Steeg PS: Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
4. Wang Y and Zhou BP: Epithelial-mesenchymal transition-A hallmark of breast cancer metastasis. Cancer Hallm 1: 38-49, 2013.
5. Bogenrieder T and Herlyn M: Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 22: 6524-6536, 2003.
6. Kong D, Li Y, Wang Z and Sarkar FH: Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel) 3: 716-729, 2011.
7. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449, 2009.
8. Micalizzi DS, Farabaugh SM and Ford HL: Epithelialmesenchymal transition in cancer: Parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117-134, 2010.
9. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009.
10. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
11. Davis FM, Stewart TA, Thompson EW and Monteith GR: Targeting EMT in cancer: Opportunities for pharmacological intervention. Trends Pharmacol Sci 35: 479-488, 2014.
12. Ginnebaugh KR, Ahmad A and Sarkar FH: The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer. Expert Opin Ther Targets 18: 731-745, 2014.
13. Ali NA, Lüdtke J, Pilgrim H and Lindequist U: Inhibition of chemiluminescence response of human mononuclear cells and suppression of mitogen-induced proliferation of spleen lymphocytes of mice by hispolon and hispidin. Pharmazie 51: 667-670, 1996.
14. Huang GJ, Deng JS, Chiu CS, Liao JC, Hsieh WT, Sheu MJ and Wu CH: Hispolon protects against acute liver damage in the rat by inhibiting lipid peroxidation, proinflammatory cytokine and oxidative stress and downregulating the expressions of iNOS, COX-2 and MMP-9. Evid Based Complement Alternat Med 2012: 480714, 2012.
15. Yang LY, Shen SC, Cheng KT, Subbaraju GV, Chien CC and Chen YC: Hispolon inhibition of inflammatory apoptosis through reduction of iNOS/NO production via HO-1 induction in macrophages. J Ethnopharmacol 156: 61-72, 2014.
16. Chen W, Zhao Z, Li L, Wu B, Chen SF, Zhou H, Wang Y and Li YQ: Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway. Free Radic Biol Med 45: 60-72, 2008.
17. Chen YC, Chang HY, Deng JS, Chen JJ, Huang SS, Lin IH, Kuo WL, Chao W and Huang GJ: Hispolon from Phellinuslinteus induces G0/G1 cell cycle arrest and apoptosis in NB4 human leukaemia cells. Am J Chin Med 41: 1439-1457, 2013.
18. Chen YS, Lee SM, Lin CC and Liu CY: Hispolon decreases melanin production and induces apoptosis in melanoma cells through the downregulation of tyrosinase and microphthalmia-associated transcription factor (MITF) expressions and the activation of caspase-3,-8 and-9. Int J Mol Sci 15: 1201-1215, 2014.
19. Huang GJ, Deng JS, Huang SS and Hu ML: Hispolon induces apoptosis and cell cycle arrest of human hepatocellular carcinoma Hep3B cells by modulating ERK phosphorylation. J Agric Food Chem 59: 7104-7113, 2011.
20. Lu TL, Huang GJ, Lu TJ, Wu JB, Wu CH, Yang TC, Iizuka A and Chen YF: Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells. Food Chem Toxicol 47: 2013-2021, 2009.
21. Derynck R, Muthusamy BP and Saeteurn KY: Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transi-tion. Curr Opin Cell Biol 31: 56-66, 2014.
22. Drabsch Y and ten Dijke P: TGF-β signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev 31: 553-568, 2012.
23. Fabregat I, Fernando J, Mainez J and Sancho P: TGF-beta signaling in cancer treatment. Curr Pharm Des 20: 2934-2947, 2014.
24. Zavadil J and Böttinger EP: TGF-beta and epithelial-to-mesen-chymal transitions. Oncogene 24: 5764-5774, 2005.
25. Friedl P and Wolf K: Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003.
26. De Craene B and Berx G: Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110, 2013.
27. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
28. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer research 72: 1878-1889, 2012.
29. Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C and Grippo PJ: TGF-β: Duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 106: djt369, 2014.
30. Jang EH, Jang SY, Cho IH, Hong D, Jung B, Park MJ and Kim JH: Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha. Biochem Biophys Res Commun 463: 917-922, 2015.
31. Kim JH, Kim YC and Park B: Hispolon from Phellinus linteus induces apoptosis and sensitizes human cancer cells to the tumor necrosis factor-related apoptosis-inducing ligand through upregulation of death receptors. Oncol Rep 35: 1020-1026, 2016.
32. Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer 105: 1885-1893, 2011.
33. Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15: 178-196, 2014.
34. Li Z, Zhang L, Ma Z, Yang M, Tang J, Fu Y, Mao Y, Hong X and Zhang Y: ETV1 induces epithelial to mesenchymal transition in human gastric cancer cells through the upregulation of Snail expression. Oncol Rep 30: 2859-2863, 2013.
35. Masui T, Ota I, Yook JI, Mikami S, Yane K, Yamanaka T and Hosoi H: Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells. Int J Oncol 44: 693-699, 2014.
36. Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009.
37. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J and García De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
38. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10: 295-305, 2008.
39. Chen ZF and Behringer RR: Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9: 686-699, 1995.
40. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004.